2022 - Ifm_05-may
Research published around May 2022 explored the impact of "early" vs. "late" discontinuation (stopping before or after 3 years), noting that early stopping is often forced by toxicity rather than choice.
Patients are encouraged to discuss the balance between disease control and the toxic long-term effects of maintenance drugs with their oncology team. IFM_05-May 2022
The study demonstrated a clear overall survival benefit for patients receiving maintenance therapy compared to a placebo. Research published around May 2022 explored the impact
